- Q1 2023 Minerva Neurosciences Inc Earnings Call TranscriptMay 15, 2023$6.44 (-11.42%)Earnings
- Q4 2022 Minerva Neurosciences Inc Earnings Call TranscriptMar 08, 2023$1.87 (-7.65%)Earnings
- Q3 2022 Minerva Neurosciences Inc Earnings Call TranscriptNov 09, 2022$3.26 (+8.85%)Earnings
- Minerva Neurosciences Inc Roluperidone Update Call TranscriptApr 13, 2022
- Q3 2021 Minerva Neurosciences Inc Earnings Call TranscriptNov 08, 2021$11.28 (+4.44%)Earnings
- Q2 2021 Minerva Neurosciences Inc Earnings Call TranscriptAug 02, 2021$14.72Earnings
- Minerva Neurosciences Inc at JMP Securities Life Sciences Virtual Conference TranscriptJun 16, 2021
- Minerva Neurosciences Inc Annual Shareholders Meeting TranscriptJun 11, 2021
- Q1 2021 Minerva Neurosciences Inc Earnings Call TranscriptMay 12, 2021$20.64 (+15.70%)Earnings
- Q4 2020 Minerva Neurosciences Inc Earnings Call TranscriptMar 08, 2021$25.52 (+11.54%)Earnings
- Q3 2020 Minerva Neurosciences Inc Earnings Call TranscriptNov 02, 2020$24.8 (-3.43%)Earnings
- Minerva Neurosciences Inc at Citi BioPharma Conference (Virtual) TranscriptSep 09, 2020
- Q2 2020 Minerva Neurosciences Inc Earnings Call TranscriptAug 03, 2020$29.52 (+5.88%)Earnings
- Minerva Neurosciences Inc Annual Shareholders Meeting TranscriptJun 19, 2020
- Minerva Neurosciences, Inc. - Special Call TranscriptJun 05, 2020
- Q1 2020 Minerva Neurosciences Inc Earnings Call TranscriptMay 04, 2020$78 (+3.83%)Earnings
- Minerva Neurosciences, Inc. - Special Call TranscriptMar 31, 2020
- Q4 2019 Minerva Neurosciences Inc Earnings Call TranscriptMar 09, 2020$57.6 (-14.59%)Earnings
- Minerva Neurosciences, Inc. - Special Call TranscriptMar 06, 2020
- Minerva Neurosciences, Inc. - Special Call TranscriptDec 18, 2019
- Q3 2019 Minerva Neurosciences Inc Earnings Call TranscriptNov 04, 2019$37.2 (+0.65%)Earnings
- Minerva Neurosciences, Inc. - Special Call TranscriptOct 01, 2019
- Q2 2019 Minerva Neurosciences Inc Earnings Call TranscriptAug 05, 2019$55.76 (+8.06%)Earnings
- Minerva Neurosciences Inc To Discuss The Results Of Its Successful Phase 2b Clinical Trial Of Seltorexant MIN-202 In Insomnia TranscriptJun 24, 2019
- Q1 2019 Minerva Neurosciences Inc Earnings Call TranscriptMay 06, 2019$57.52 (-5.15%)Earnings
- Minerva Neurosciences, Inc. - Special Call TranscriptMar 21, 2019
- Q4 2018 Minerva Neurosciences Inc Earnings Call TranscriptMar 12, 2019$64.88 (-0.37%)Earnings
Minerva Neurosciences, Inc. - Special Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Minerva Neurosciences December 18, 2019 Conference Call. (Operator Instructions)
I would now like to hand the conference to your speaker today, William Boni, Vice President of Investor Relations. Please go ahead, sir.
Good evening, everyone. A press release announcing top line results from the Phase IIb trial of MIN-117 became available at 4:05 p.m. Eastern Time today and can be found on the Investors section of our website.
Joining me on the call today from Minerva are Dr. Rémy Luthringer, Executive Chairman and Chief Executive Officer; Mr. Geoff Race, Executive Vice President, Chief Financial Officer and Chief Business Officer; and Mr. Rick Russell, President. Following our prepared remarks, we will open the call for Q&A.
Before we begin, I would like to remind you that today's discussion will include statements about the company's future expectations, plans and prospects
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)